
STCUBE — Investor Relations & Filings
STCube is a biopharmaceutical company specializing in the research and development of innovative immuno-oncology therapies. The company focuses on discovering treatments that target novel immune checkpoints to overcome cancer's immune evasion mechanisms. Its primary area of research involves BTN1A1, a novel immune checkpoint target often expressed in a mutually exclusive manner with PD-L1. STCube's lead drug candidate, Nelmastobart, is a first-in-class anti-BTN1A1 immune checkpoint inhibitor. This therapy is being developed to provide a new treatment option for patients with treatment-resistant, refractory, or recurrent cancers that have limited therapeutic alternatives. The company utilizes a precision-medicine, biomarker-driven approach in its clinical development programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 정기주주총회결과 | 2026-03-26 | Korean | |
| 사업보고서 (2025.12) | 2026-03-18 | Korean | |
| 감사보고서제출 | 2026-03-18 | Korean | |
| [기재정정]주주총회소집공고 | 2026-02-25 | Korean | |
| 의결권대리행사권유참고서류 | 2026-02-25 | Korean | |
| 주주총회소집공고 | 2026-02-24 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 33047279 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 32973769 | 사업보고서 (2025.12) | 2026-03-18 | Korean | ||
| 32972286 | 감사보고서제출 | 2026-03-18 | Korean | ||
| 32837832 | [기재정정]주주총회소집공고 | 2026-02-25 | Korean | ||
| 32837795 | 의결권대리행사권유참고서류 | 2026-02-25 | Korean | ||
| 32832796 | 주주총회소집공고 | 2026-02-24 | Korean | ||
| 32543172 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2026-02-20 | Korean | ||
| 32543060 | 주주총회소집결의 | 2026-02-20 | Korean | ||
|
2025
7 filings
| |||||
| 33024417 | 투자판단관련주요경영사항(임상시험계획승인신청등결정) (Nelmastobart(hSTC810)의 진행성/전이성 비소세포폐암 제2상 임상시험계획 승인) | 2025-10-16 | Korean | ||
| 7863621 | 기업설명회(IR)개최 | 2025-09-18 | Korean | ||
| 7869716 | 투자판단관련주요경영사항(임상시험계획자진취하등) (면역항암제 hSTC810 의 미국 식품의약국(FDA) 제1b/2상 임상 시험계획(IND) 자진취하) | 2025-08-25 | Korean | ||
| 7869715 | 투자판단관련주요경영사항(임상시험계획승인신청) (Nelmastobart(hSTC810)의 진행성/전이성 비소세포폐암 제2상 임상시험계획 신청) | 2025-08-25 | Korean | ||
| 7872883 | [기재정정]사업보고서 (2024.12) | 2025-08-14 | Korean | ||
| 7872801 | 반기보고서 (2025.06) | 2025-08-14 | Korean | ||
| 7888636 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-06-30 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
STCUBE via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15507/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15507 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15507 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15507 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15507}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for STCUBE (id: 15507)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.